Cargando…

APVO210: A Bispecific Anti-CD86-IL-10 Fusion Protein (ADAPTIR™) to Induce Antigen-Specific T Regulatory Type 1 Cells

IL-10 is a potent immunosuppressive cytokine that promotes the differentiation of tolerogenic dendritic cells (DC-10), and the subsequent induction of antigen-specific T regulatory type 1 (Tr1) cells, which suppress immune responses. However, IL-10 acts on multiple cell types and its effects are not...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pellerin, Laurence, Chen, Ping, Gregori, Silvia, Hernandez-Hoyos, Gabriela, Bacchetta, Rosa, Roncarolo, Maria Grazia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5980965/ https://www.ncbi.nlm.nih.gov/pubmed/29887861 http://dx.doi.org/10.3389/fimmu.2018.00881

Ejemplares similares

The decay of $^{210}_{86}$Rn$_{124}$ to levels in $^{210}_{85}$At$_{125}$
por: Jonson, B, et al.
Publicado: (1972)

Risk, Characteristics and Biomarkers of Cytokine Release Syndrome in Patients with Relapsed/Refractory AML or MDS Treated with CD3xCD123 Bispecific Antibody APVO436
por: Uckun, Fatih M., et al.
Publicado: (2021)

Type 1 regulatory T (Tr1) cells: from the bench to the bedside
por: Gregori, Silvia, et al.
Publicado: (2012)

A Clinical Phase 1B Study of the CD3xCD123 Bispecific Antibody APVO436 in Patients with Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome
por: Uckun, Fatih M., et al.
Publicado: (2021)

Engineered T Regulatory Type 1 Cells for Clinical Application
por: Gregori, Silvia, et al.
Publicado: (2018)

Post-hoc Analysis of Pharmacodynamics and Single-Agent Activity of CD3xCD123 Bispecific Antibody APVO436 in Relapsed/Refractory AML and MDS Resistant to HMA or Venetoclax Plus HMA
por: Watts, Justin, et al.
Publicado: (2022)

The decay of /sup 210//sub 86/Rn/sub 124/ to levels in /sup 210//sub 85/At/sub 125/
por: Jonson, B, et al.
Publicado: (1973)

The Cellular and Molecular Mechanisms of Immuno-Suppression by Human Type 1 Regulatory T Cells
por: Gregori, Silvia, et al.
Publicado: (2012)

Clinical Outlook for Type-1 and FOXP3(+) T Regulatory Cell-Based Therapy
por: Gregori, Silvia, et al.
Publicado: (2015)

An anti-CD45RO/RB monoclonal antibody modulates T cell responses via induction of apoptosis and generation of regulatory T cells
por: Gregori, Silvia, et al.
Publicado: (2005)

IL-6-miR-210 Suppresses Regulatory T Cell Function and Promotes Atrial Fibrosis by Targeting Foxp3
por: Chen, YingWei, et al.
Publicado: (2020)

BHLHE40 Regulates IL-10 and IFN-γ Production in T Cells but Does Not Interfere With Human Type 1 Regulatory T Cell Differentiation
por: Uyeda, Molly Javier, et al.
Publicado: (2021)

Killing of myeloid APCs via HLA class I, CD2 and CD226 defines a novel mechanism of suppression by human Tr1 cells
por: Magnani, Chiara F, et al.
Publicado: (2011)

Engineered type 1 regulatory T cells designed for clinical use kill primary pediatric acute myeloid leukemia cells
por: Cieniewicz, Brandon, et al.
Publicado: (2020)

EGF-IL2 bispecific and bivalent EGF fusion toxin efficacy against syngeneic head and neck cancer mouse models
por: Qiu, Yue, et al.
Publicado: (2022)

IL-10-Engineered Human CD4(+) Tr1 Cells Eliminate Myeloid Leukemia in an HLA Class I-Dependent Mechanism
por: Locafaro, Grazia, et al.
Publicado: (2017)

Granulocyte-colony stimulating factor drives the in vitro differentiation of human dendritic cells that induce anergy in naïve T cells
por: Rossetti, Maura, et al.
Publicado: (2010)

Bispecific soluble cytokine receptor-nanobody fusions inhibit Interleukin (IL-)6 trans-signaling and IL-12/23 or tumor necrosis factor (TNF) signaling
por: Gesiorowski, Annika, et al.
Publicado: (2023)

Bispecific antibodies in cancer therapy: Target selection and regulatory requirements
por: Sun, Yanze, et al.
Publicado: (2023)

(226)Ra, (210)Pb, (210)Bi and (210)Po deposition and removal from surfaces and liquids
por: Wójcik, M., et al.
Publicado: (2012)

Differentiation of T Regulatory Cells by Immature Dendritic Cells
por: Roncarolo, Maria-Grazia, et al.
Publicado: (2001)

EXM-86-11: 26/6/86
por: Daems, G
Publicado: (1986)

EXM-86-24: 6/11/86
por: Martucci, P
Publicado: (1986)

EXM-86-21: 16/10/86
por: Martucci, P
Publicado: (1986)

EXM-86-30: 18/12/86
por: Martucci, PP, et al.
Publicado: (1987)

Type 1 regulatory T cell-mediated tolerance in health and disease
por: Freeborn, Robert A., et al.
Publicado: (2022)

Strategy for recruitment and factors associated with motivation and satisfaction in a randomized trial with 210 healthy volunteers without financial compensation
por: Luzurier, Quentin, et al.
Publicado: (2015)

SEUGI '86
Publicado: (1986)

Antiproton 86
por: Papastefanou, C, et al.
Publicado: (1987)

Rapamycin Combined with Anti-CD45RB mAb and IL-10 or with G-CSF Induces Tolerance in a Stringent Mouse Model of Islet Transplantation
por: Gagliani, Nicola, et al.
Publicado: (2011)

A phase II study of the bispecific antibody MDX-H210 (anti-HER2 × CD64) with GM-CSF in HER2+ advanced prostate cancer
por: James, N D, et al.
Publicado: (2001)

Regulatory T cells are redirected to kill glioblastoma by an EGFRvIII-targeted bispecific antibody
por: Choi, Bryan D, et al.
Publicado: (2013)

Transition probabilities of low-lying excited states in 210Po and 210Pb
por: Georgiev, Georgi, et al.
Publicado: (2022)

Determination of the mean aerosol residence times in the atmosphere and additional (210)Po input on the base of simultaneous determination of (7)Be, (22)Na, (210)Pb, (210)Bi and (210)Po in urban air
por: Długosz-Lisiecka, Magdalena, et al.
Publicado: (2012)

The Yin and Yang of Type 1 Regulatory T Cells: From Discovery to Clinical Application
por: Sayitoglu, Ece Canan, et al.
Publicado: (2021)

Coexpression of CD163 and CD141 identifies human circulating IL-10-producing dendritic cells (DC-10)
por: Comi, Michela, et al.
Publicado: (2019)

Aryl hydrocarbon receptor activity downstream of IL-10 signaling is required to promote regulatory functions in human dendritic cells
por: Avancini, Daniele, et al.
Publicado: (2023)

Functional type 1 regulatory T cells develop regardless of FOXP3 mutations in patients with IPEX syndrome
por: Passerini, Laura, et al.
Publicado: (2011)

Immunological Outcome in Haploidentical-HSC Transplanted Patients Treated with IL-10-Anergized Donor T Cells
por: Bacchetta, Rosa, et al.
Publicado: (2014)

Radionuclides ((210)Po and (210)Pb) and Some Heavy Metals in Fish and Sediments in Lake Bafa, Turkey, and the Contribution of (210)Po to the Radiation Dose
por: Manav, Ramazan, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_vb1rp1uvvju4dl66fjar9di7qd